Brighton Jones LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $2.25M | Buy |
|
|||||
|
2025
Q2 | $336K | Sell |
|
|||||
|
2025
Q1 | $326K | Buy |
|
|||||
|
2024
Q4 | $243K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $693K | Buy |
|
|||||
|
2023
Q2 | $717K | Buy |
|
|||||
|
2023
Q1 | $752K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $390K | Sell |
|
|||||
|
2018
Q1 | $477K | Sell |
|
|||||
|
2017
Q4 | $511K | Buy |
|
|||||
|
2017
Q3 | $471K | Hold |
|
|||||
|
2017
Q2 | $320K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $266K | Buy |
|